Recombinant Human CPXCR1 Protein，GST

CPXCR1, a receptor belonging to the chemokine receptor family, has garnered significant attention in recent years due to its potential roles in immune responses and various pathological conditions. Research on CPXCR1 has particularly intensified in the context of its involvement in hematopoietic processes and its implication in inflammation and autoimmune diseases. The receptor is believed to play a crucial role in regulating leukocyte trafficking, influencing how immune cells migrate to sites of inflammation or injury. Furthermore, studies have suggested that CPXCR1 may also have a role in cancer progression by modulating the tumor microenvironment and facilitating metastasis. As a result, the recombinant production of CPXCR1 has become a pivotal focus for researchers aiming to better understand its structure-function relationships and interactions with ligands. The ability to generate CPXCR1 as a recombinant protein allows for detailed biochemical studies, paving the way for the development of potential therapeutic strategies targeting this receptor. By employing techniques such as site-directed mutagenesis and advanced structural analysis, scientists hope to elucidate the molecular mechanisms underlying CPXCR1 signaling pathways. This research not only aims to unravel the complexities of immune regulation but also aspires to contribute to the design of novel treatments for conditions associated with dysregulated CPXCR1 activity, making it a crucial area of investigation in the field of immunology and translational medicine.